Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors


Oyan Uluç B. , Sönmez Ö. , Yazar A. , Teomete M.

American Society of Clinical Oncology (ASCO) Annual Meeting, Illinois, United States Of America, 1 - 05 June 2018, pp.2436

  • Publication Type: Conference Paper / Summary Text
  • Doi Number: 10.1200/jco.2018.36
  • City: Illinois
  • Country: United States Of America
  • Page Numbers: pp.2436